|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.09 INR | -0.57% |
|
-2.43% | +2.11% |
| Market Cap | 439M 4.61M 4.03M 3.7M 3.45M 6.55M 6.65M 44.48M 17.29M 216M 17.31M 16.94M 744M | P/E 2024 |
-16.2x | P/E 2025 | 17.5x |
|---|---|---|---|---|---|
| Enterprise Value | 1.38B 14.45M 12.63M 11.61M 10.82M 20.52M 20.83M 139M 54.16M 676M 54.23M 53.06M 2.33B | EV / Sales 2024 |
0.69x | EV / Sales 2025 | 0.66x |
| Free-Float |
63.32% | Yield 2024 * |
-
| Yield 2025 | - |
| 04/02/22 | Mangalam Drugs & Organics : Resignation | PU |
| 1 day | -0.57% | ||
| 1 week | -2.43% | ||
| Current month | -0.18% | ||
| 1 month | -0.53% | ||
| 3 months | -4.94% | ||
| 6 months | -7.35% | ||
| Current year | +2.11% |
| 1 week | 27.53 |  | 29.46 |
| 1 month | 27 | | 31.05 |
| Current year | 26.51 | | 54.4 |
| 1 year | 22.8 | | 95 |
| 3 years | 22.8 | | 144.99 |
| 5 years | 22.8 | | 196.95 |
| 10 years | 20.65 | | 225.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 72 | 30/09/2011 | |
| Director of Finance/CFO | - | 06/02/2026 | |
Shweta Patel
CMP | Compliance Officer | 27 | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 02/02/2010 | |
| Director/Board Member | 75 | 05/02/2015 | |
Nidhi S. Mundada
BRD | Director/Board Member | 37 | 28/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.57% | -2.43% | - | - | 4.72M | |
| +1.81% | +2.25% | +13.40% | +84.45% | 48B | |
| -2.54% | +3.72% | +65.71% | +113.61% | 36.89B | |
| +0.15% | +1.26% | -3.35% | +45.56% | 12.37B | |
| +3.71% | +3.56% | +14.13% | +97.20% | 11.95B | |
| +0.39% | +0.58% | +33.25% | +119.07% | 9.01B | |
| +0.66% | -0.57% | +19.28% | +45.55% | 7.2B | |
| +0.71% | +1.75% | +53.59% | -7.09% | 7.05B | |
| +0.68% | +2.63% | +23.97% | +235.28% | 6.55B | |
| +9.99% | +32.94% | -15.69% | +27.08% | 6.58B | |
| Average | +1.50% | +4.24% | +22.70% | +84.52% | 16.18B | |
| Weighted average by Cap. | +0.84% | +3.35% | +27.92% | +89.56% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.67B 38.58M 33.73M 31M 28.89M 54.8M 55.63M 372M 145M 1.81B 145M 142M 6.22B | 3.18B 33.35M 29.16M 26.8M 24.98M 47.37M 48.09M 322M 125M 1.56B 125M 123M 5.38B |
| Net income | -90.72M -953K -833K -765K -713K -1.35M -1.37M -9.19M -3.57M -44.59M -3.58M -3.5M -154M | 67.21M 706K 617K 567K 529K 1M 1.02M 6.81M 2.65M 33.04M 2.65M 2.59M 114M |
| Net Debt | 1.06B 11.11M 9.71M 8.93M 8.32M 15.78M 16.02M 107M 41.66M 520M 41.71M 40.82M 1.79B | 936M 9.83M 8.6M 7.9M 7.36M 13.97M 14.18M 94.86M 36.87M 460M 36.92M 36.12M 1.59B |
Employees
480
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/07/26 | ₹28.09 | -0.57% | 112,128 |
| 02/07/26 | ₹28.25 | -0.67% | 31,493 |
| 01/07/26 | ₹28.44 | +1.07% | 31,330 |
| 30/06/26 | ₹28.14 | -0.95% | 30,111 |
| 29/06/26 | ₹28.41 | -1.32% | 25,281 |
- Stock Market
- Stocks
- MANGALAM Stock
- MANGALAM Stock
Select your edition
All financial news and data tailored to specific country editions
